SCHEMBL1502047

SCHEMBL1502047

CS(=O)(=O)N1CCC(CN2CCOC(CNC(=O)c3cc(Cl)c(N)c4c3OCC4)C2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 5/20 0.47
HTR3A P46098 2/20 0.47
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
HTR1A P08908 2/20 0.46
KCNH2 Q12809 2/20 0.46
ADRA2C P18825 1/20 0.46
ACHE P22303 1/20 0.46
PTGS1 P23219 1/20 0.46
ADRA1A P35348 1/20 0.46
ALDH1A1 P00352 1/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1501947 0.89 HTR4 (0.48) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL1502439 0.88 HTR4 (0.50) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL8004726 0.88 HTR4 (0.48) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL1502005 0.87 HTR4 (0.49) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL1502034 0.87 HTR4 (0.46) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL1502164 0.87 HTR4 (0.49) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL1502316 0.87 HTR4 (0.47) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL1502105 0.87 HTR4 (0.47) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL3402337 0.85 HTR4 (0.46) HTR4HTR3AHTR3EHTR3BHTR3D
SCHEMBL1502238 0.85 HTR4 (0.46) HTR4HTR3AHTR3EHTR3BHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256114-B1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAINIPPON SUMITOMO PHARMA CO (JP) 2014-06-25 EP claimed
US-7906510-B2 Amide derivative and pharmaceutical composition containing the same Dainippon Sumito Pharma Co., Ltd. (JP) 2011-03-15 US claimed
EP-2256114-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Dainippon Sumitomo Pharma Co., Ltd. (JP) 2010-12-01 EP claimed
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Sumitomo Pharma Co., Ltd. (JP) 2010-09-30 US claimed
EP-2256114-B1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAINIPPON SUMITOMO PHARMA CO (JP) 2014-06-25 EP disclosed
US-7906510-B2 Amide derivative and pharmaceutical composition containing the same Dainippon Sumito Pharma Co., Ltd. (JP) 2011-03-15 US disclosed
EP-2256114-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Dainippon Sumitomo Pharma Co., Ltd. (JP) 2010-12-01 EP disclosed
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Sumitomo Pharma Co., Ltd. (JP) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME HTR4, MC2R, HTR1D HTR4 1/4885HTR3A 46/4885HTR3E 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.